Dengue Vaccines Market:Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Apr 2021| TMR2323A| Transparency

Report Highlights

Dengue Vaccines Market – Scope of the Report

TMR’s report on the global dengue vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global dengue vaccines market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dengue vaccines market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dengue vaccines market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the dengue vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global dengue vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dengue vaccines market.

The report delves into the competitive landscape of the global dengue vaccines market. Key players operating in the global dengue vaccines market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dengue vaccines market profiled in this report.

Key Questions Answered in Dengue Vaccines Market Report

  • What is the sales/revenue generated by dengue vaccines across all regions during the forecast period?
  • What are the opportunities in the global dengue vaccines market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which category is expected to generate the highest revenue globally in 2031? Which product is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Dengue Vaccines Market – Research Objectives and Research Approach

The comprehensive report on the global dengue vaccines market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global dengue vaccines market in terms of category, product, route of administration, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dengue vaccines market.

  • Table 1 : Global Dengue Vaccines Market Value (US$ Mn) Forecast, by Category, 2017-2031
  • Table 2 : Global Dengue Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 3 : Global Dengue Vaccines Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 4 : Global Dengue Vaccines Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 5 : North America Dengue Vaccines Market Value (US$ Mn) Forecast, by Sub-region, 2017-2031
  • Table 6 : North America Dengue Vaccines Market Value (US$ Mn) Forecast, by Category, 2017-2031
  • Table 7 : North America Dengue Vaccines Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 8 : North America Dengue Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 9 : North America Dengue Vaccines Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10 : Europe Dengue Vaccines Market Value (US$ Mn) Forecast, by Sub-region, 2017-2031
  • Table 11 : Europe Dengue Vaccines Market Value (US$ Mn) Forecast, by Category, 2017-2031
  • Table 12 : Europe Dengue Vaccines Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13 : Europe Dengue Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 14 : Europe Dengue Vaccines Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15 : Asia Pacific Dengue Vaccines Market Value (US$ Mn) Forecast, by Sub-region, 2017-2031
  • Table 16 : Asia Pacific Dengue Vaccines Market Value (US$ Mn) Forecast, by Category, 2017-2031
  • Table 17 : Asia Pacific Dengue Vaccines Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18 : Asia Pacific Dengue Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 19 : Asia Pacific Dengue Vaccines Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20 : Latin America Dengue Vaccines Market Value (US$ Mn) Forecast, by Sub-region, 2017-2031
  • Table 21 : Latin America Dengue Vaccines Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 22 : Latin America Dengue Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 23 : Latin America Dengue Vaccines Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 24 : Middle East & Africa Dengue Vaccines Market Value (US$ Mn) Forecast, by Sub-region, 2017-2031
  • Table 25 : Middle East & Africa Dengue Vaccines Market Value (US$ Mn) Forecast, by Category, 2017-2031
  • Table 26 : Middle East & Africa Dengue Vaccines Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27 : Middle East & Africa Dengue Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 28 : Middle East & Africa Dengue Vaccines Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 1 : Global Dengue Vaccines Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 2 : Global Dengue Vaccines Market Value Share, by Category, 2020
  • Figure 3 : Global Dengue Vaccines Market Value Share, by Product, 2020
  • Figure 4 : Global Dengue Vaccines Market Value Share, by End-user, 2020
  • Figure 5 : Global Dengue Vaccines Market Value Share, by Region, 2020
  • Figure 6 : Global Dengue Vaccines Market Value Share, by Route of Administration, 2020
  • Figure 7 : Global Dengue Vaccines Market Value Share Analysis, by Category, 2020 and 2031
  • Figure 8 : Global Dengue Vaccines Market Attractiveness Analysis, by Category, 2021-2031
  • Figure 9 : Global Dengue Vaccines Market Value (US$ Mn), by Live Attenuated Vaccines Category, 2017-2031
  • Figure 10 : Global Dengue Vaccines Market Value (US$ Mn), by Chimeric Live Attenuated Vaccines Category, 2017-2031
  • Figure 11 : Global Dengue Vaccines Market Value (US$ Mn), by Others Category, 2017-2031
  • Figure 12 : Global Dengue Vaccines Market Value Share Analysis, by Route of Administration, 2020 and 2031
  • Figure 13 : Global Dengue Vaccines Market Attractiveness Analysis, by Route of Administration, 2021-2031
  • Figure 14 : Global Dengue Vaccines Market Value (US$ Mn), by Subcutaneous, 2017-2031
  • Figure 15 : Global Dengue Vaccines Market Value (US$ Mn), by Others, 2017-2031
  • Figure 16 : Global Dengue Vaccines Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 17 : Global Dengue Vaccines Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 18 : Global Dengue Vaccines Market Value (US$ Mn), by Hospitals, 2017-2031
  • Figure 19 : Global Dengue Vaccines Market Value (US$ Mn), by Government institutes, 2017-2031
  • Figure 20 : Global Dengue Vaccines Market Value (US$ Mn), by Specialty Clinics, 2017-2031
  • Figure 21 : Global Dengue Vaccines Market Value (US$ Mn), by Others, 2017-2031
  • Figure 22 : Global Dengue Vaccines Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 23 : Global Dengue Vaccines Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 24 : North America Dengue Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 25 : North America Dengue Vaccines Market Value Share, by Sub-region, 2020-2031
  • Figure 26 : North America Dengue Vaccines Market Attractiveness Analysis, by Sub-region, 2021-2031
  • Figure 27 : North America Dengue Vaccines Market Value Share Analysis, by Category, 2020 and 2031
  • Figure 28 : North America Dengue Vaccines Market Attractiveness Analysis, by Category, 2021-2031
  • Figure 29 : North America Dengue Vaccines Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 30 : North America Dengue Vaccines Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 31 : North America Dengue Vaccines Market Value Share Analysis, by Route of Administration, 2020 and 2031
  • Figure 32 : North America Dengue Vaccines Market Attractiveness Analysis, by Route of Administration, 2021-2031
  • Figure 33 : North America Dengue Vaccines Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 34 : North America Dengue Vaccines Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 35 : Europe Dengue Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 36 : Europe Dengue Vaccines Market Value Share, by Sub-region, 2020-2031
  • Figure 37 : Europe Dengue Vaccines Market Attractiveness Analysis, by Sub-region, 2021-2031
  • Figure 38 : Europe Dengue Vaccines Market Value Share Analysis, by Category, 2020 and 2031
  • Figure 39 : Europe Dengue Vaccines Market Attractiveness Analysis, by Category, 2021-2031
  • Figure 40 : Europe Dengue Vaccines Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 41 : Europe Dengue Vaccines Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 42 : Europe Dengue Vaccines Market Value Share Analysis, by Route of Administration, 2020 and 2031
  • Figure 43 : Europe Dengue Vaccines Market Attractiveness Analysis, by Route of Administration, 2021-2031
  • Figure 44 : Europe Dengue Vaccines Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 45 : Europe Dengue Vaccines Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 46 : Asia Pacific Dengue Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 47 : Asia Pacific Dengue Vaccines Market Value Share, by Sub-region, 2020-2031
  • Figure 48 : Asia Pacific Dengue Vaccines Market Attractiveness Analysis, by Sub-region, 2021-2031
  • Figure 49 : Asia Pacific Dengue Vaccines Market Value Share Analysis, by Category, 2020 and 2031
  • Figure 50 : Asia Pacific Dengue Vaccines Market Attractiveness Analysis, by Category, 2021-2031
  • Figure 51 : Asia Pacific Dengue Vaccines Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 52 : Asia Pacific Dengue Vaccines Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 53 : Asia Pacific Dengue Vaccines Market Value Share Analysis, by Route of Administration, 2020 and 2031
  • Figure 54 : Asia Pacific Dengue Vaccines Market Attractiveness Analysis, by Route of Administration, 2021-2031
  • Figure 55 : Asia Pacific Dengue Vaccines Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 56 : Asia Pacific Dengue Vaccines Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 57 : Latin America Dengue Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 58 : Latin America Dengue Vaccines Market Value Share, by Sub-region, 2020-2031
  • Figure 59 : Latin America Dengue Vaccines Market Attractiveness Analysis, by Sub-region, 2021-2031
  • Figure 60 : Latin America Dengue Vaccines Market Value Share Analysis, by Category, 2020 and 2031
  • Figure 61 : Latin America Dengue Vaccines Market Attractiveness Analysis, by Category, 2021-2031
  • Figure 62 : Latin America Dengue Vaccines Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 63 : Latin America Dengue Vaccines Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 64 : Latin America Dengue Vaccines Market Value Share Analysis, by Route of Administration, 2020 and 2031
  • Figure 65 : Latin America Dengue Vaccines Market Attractiveness Analysis, by Route of Administration, 2021-2031
  • Figure 66 : Latin America Dengue Vaccines Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 67 : Latin America Dengue Vaccines Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 68 : Middle East & Africa Dengue Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 69 : Middle East & Africa Dengue Vaccines Market Value Share, by Sub-region, 2020-2031
  • Figure 70 : Middle East & Africa Dengue Vaccines Market Attractiveness Analysis, by Sub-region, 2021-2031
  • Figure 71 : Middle East & Africa Dengue Vaccines Market Value Share Analysis, by Category, 2020 and 2031
  • Figure 72 : Middle East & Africa Dengue Vaccines Market Attractiveness Analysis, by Category, 2021-2031
  • Figure 73 : Middle East & Africa Dengue Vaccines Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 74 : Middle East & Africa Dengue Vaccines Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 75 : Middle East & Africa Dengue Vaccines Market Value Share Analysis, by Route of Administration, 2020 and 2031
  • Figure 76 : Middle East & Africa Dengue Vaccines Market Attractiveness Analysis, by Route of Administration, 2021-2031
  • Figure 77 : Middle East & Africa Dengue Vaccines Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 78 : Middle East & Africa Dengue Vaccines Market Attractiveness Analysis, by End-user, 2021-2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS